OMNICELL, INC.
Close on Oct 19, 2026
- Market cap
- $1.66B
- P/E (TTM)
- 42.1
- Dividend yield
- –
About Omnicell
Electronic Computers, SIC 3571
Omnicell develops healthcare technology and medication management systems. The company provides automated dispensing cabinets, central pharmacy robotics, intravenous sterile compounding systems, and medication adherence packaging equipment and supplies. It also offers technical and professional support, as well as software platforms such as the OmniSphere intelligence ecosystem and the EnlivenHealth patient engagement platform. Omnicell manages its business operations within a single reporting segment. Its customer base includes hospitals, health systems, institutional long-term care facilities, ambulatory clinics, and retail and outpatient pharmacies.
The company's systems and services operate across thousands of healthcare facilities. Omnicell conducts business in the United States and internationally, offering medication tracking and dispensing hardware and software in overseas regions, including the European Union and the United Kingdom. The provided text does not specify the location of the company's corporate headquarters.
Summary of the business section of Omnicell's latest annual report, written by StockData.
Company profile
Company
- Legal name
- OMNICELL, INC.
- Headquarters
- Fort Worth, TX
- Address
- 4220 North Freeway 76137
- Phone
- (877) 415-9990
- Employees
- 3,580, Dec 31, 2025
- Industry
- Electronic Computers
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, San Jose, California
Stock & identifiers
- Ticker
- OMCL
- Exchange
- Nasdaq
- IPO date
- Aug 7, 2001
- Shares outstanding
- 46M, Jul 29, 2026
- Public float
- $1.30B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 926326
- CUSIP
- 68213N109
- ISIN
- US68213N1090
- LEI
- 5493008RH0GTKHHPZI77
- EIN
- 94-3166458
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Randall A. Lipps | CHAIRMAN, CEO, Director | 865,008 |
| Corey J. Manley | EVP&CHIEF LEGAL/ADMIN OFFICER | 108,985 |
| Nnamdi Njoku | President & COO | 161,224 |
| Brian H. Nutt | VP, Chief Accounting Officer | 22,266 |
| Harlan Baird Radford | EVP & Chief Financial Officer | 69,969 |
| Mary Garrett | Director | 22,202 |
| Bruce E. Scott | Director | 27,600 |
| Kaushik Ghoshal | Director | 19,123 |
| Eileen J. Voynick | Director | 20,011 |
| Edward Peter Bousa | Director | 22,589 |
| Robin Gene Seim | Director | 52,198 |
| Joanne B. Bauer | Director | 49,922 |
| Mark W. Parrish | Director | 70,100 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr.Lipps | $7.53M | $2.41M | $2.49M | $38 | $81 |
| FY2024 Mr.Lipps | $8.17M | $14.85M | $2.86M | $37 | $66 |
| FY2023 Mr.Lipps | $11.02M | $4.28M | $2.96M | $31 | $68 |
| FY2022 Mr.Lipps | $7.90M | -$13.26M | $2.42M | $42 | $68 |
| FY2021 Mr.Lipps | $8.44M | $23.01M | $3.38M | $150 | $90 |
| FY2020 Mr.Lipps | $8.03M | $15.53M | $2.25M | $147 | $127 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had approximately 3,580 employees worldwide (with approximately 3,140 located in either the United States or Canada), excluding individuals who are classified as temporary or contractors.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Dec 8, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Jan 6, 2016 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 20, 2015 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Mar 2, 2015 | Late filing | Notification of late filing |
| Apr 8, 2014 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Aug 3, 2012 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| May 22, 2012 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Mar 16, 2007 | Late filing | Notification of late filing |
| Aug 7, 2001 | IPO | Initial public offering priced (424B4 prospectus) |
| Mar 9, 2001 | Name change | Name changed from OMNICELL COM /CA/ to OMNICELL INC /CA/ |